BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc.
(NASDAQ: HX) ("Xiaobai Maimai" or the "Company"), today announced
that it held the 2021 annual general meeting of shareholders (the
"AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road,
Futian District, Shenzhen 518408,
People's Republic of China, at
10:00 a.m. (Beijing Time) on
December 3, 2021. At the AGM, holders
of 71,057,650 ordinary shares (including ordinary shares
represented by the Company's American Depositary Shares), out of
the 71,478,550 ordinary shares issued and outstanding, were present
in person or by proxy, and therefore constituted a quorum of more
than one-third of the ordinary shares outstanding and entitled to
vote at the AGM as of October 29,
2021, the record date of the AGM.
At the AGM, the shareholders of the Company approved the name
change of the Company from "Xiaobai Maimai Inc." to "Akso Health
Group," as a special resolution of the Company. As an ordinary
resolution of the Company, the shareholders ratified the
appointment of Wei, Wei & Co., LLP as the Company's independent
registered public accounting firm.
About Xiaobai Maimai Inc.
Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai
Inc., ("Xiaobai Maimai" or the "Company"), is currently engaged in
two lines of business, i.e. a social e-commerce platform based
in Beijing, China and the planned cancer therapy and
radiation oncology business.
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements are made under the "safe
harbor" provisions of the U.S. Private Securities Litigation Reform
Act of 1995. These statements can be identified by terminology such
as "will," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," "potential," "continue," "ongoing,"
"targets," "guidance" and similar statements. The Company may also
make written or oral forward-looking statements in its periodic
reports to the U.S. Securities and Exchange Commission (the "SEC"),
in its annual report to shareholders, in press releases and other
written materials and in oral statements made by its officers,
directors or employees to third parties. Any statements that are
not historical facts, including statements about the Company's
beliefs and expectations, are forward-looking statements that
involve factors, risks and uncertainties that could cause actual
results to differ materially from those in the forward-looking
statements. Such factors and risks include, but not limited to the
following: risks related to our ability to obtain equipment,
technology, license and talents at satisfactory terms to start the
planned business, if at all; risks regarding the effect of the
COVID-19 pandemic on the Company and the Company's position in a
post-COVID-19 environment; risks related to the Company's ability
to adapt and make the necessary adjustments to compete and operate
effectively; risks related to decisions or changes in governmental
or private insurers' reimbursement levels for our radiotherapy
services or our ability to obtain reimbursement for our
radiotherapy services; risks related to increased competition and
the development of new competing services; the risk that we may be
unable to develop or achieve commercial success for radiotherapy
services in a timely manner, or at all; risks related to regulatory
requirements or enforcement in the United States and
changes in the structure of the healthcare system or healthcare
payment systems; risks related to our ability to successfully
integrate and derive benefits from any technologies that we license
or acquire; risks related to our projections about our business,
results of operations and financial condition; and risks related to
the potential market opportunity for our products and services.
Further information regarding these and other risks, uncertainties
or factors is included in the Company's filings with the SEC. All
information provided in this announcement is current as of the date
of this announcement, and the Company does not undertake any
obligation to update such information, except as required under
applicable law.
For more information, please
visit ir.xiaobaimaimai.com
For investor inquiries, please contact:
The Company
Investor Relations
Ms. Zenabo Ma
Email: ir@xiaobaimaimai.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-10- 5900-1548
E-mail: Eyuan@christensenir.com
In US
Mr. Tip Fleming
Phone: +1-917-412-3333
Email: tfleming@Christensenir.com
View original
content:https://www.prnewswire.com/news-releases/xiaobai-maimai-announces-the-results-of-annual-general-meeting-and-name-change-301437257.html
SOURCE Xiaobai Maimai Inc.